Although there are no clear explanations of how Bcl-xL could confer chemo-resistance, the aggressiveness induced by an over-expression of Bcl-xL has been often associated to its capacity to induce drug resistance in cancer from different origins [100,101,102]. This evidence concerns the gene BCL2L1 and cancer.